2021 Form 10-K Financial Statement

#000121390022014844 Filed on March 24, 2022

View on sec.gov

Income Statement

Concept 2021 2020
Revenue $88.16K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.57M $8.010M
YoY Change 32.01% 152.68%
% of Gross Profit
Research & Development $21.30M $10.68M
YoY Change 99.45% 21.09%
% of Gross Profit
Depreciation & Amortization $111.5K $0.00
YoY Change
% of Gross Profit
Operating Expenses $31.87M $18.69M
YoY Change 70.54% 55.88%
Operating Profit -$31.79M
YoY Change
Interest Expense $51.23K $130.0K
YoY Change -60.59% 8.33%
% of Operating Profit
Other Income/Expense, Net $696.7K
YoY Change
Pretax Income -$31.04M -$18.57M
YoY Change 67.14% 56.44%
Income Tax
% Of Pretax Income
Net Earnings -$31.04M -$18.57M
YoY Change 67.14% 56.44%
Net Earnings / Revenue -35207.25%
Basic Earnings Per Share -$1.25
Diluted Earnings Per Share -$1.251M -$909.0K
COMMON SHARES
Basic Shares Outstanding 24.82M shares
Diluted Shares Outstanding 24.82M shares

Balance Sheet

Concept 2021 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.79M $35.30M
YoY Change -4.26% 25.67%
Cash & Equivalents $33.79M $35.30M
Short-Term Investments
Other Short-Term Assets $2.448M $2.260M
YoY Change 8.32% 107.34%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $38.84M $37.56M
YoY Change 3.4% 28.67%
LONG-TERM ASSETS
Property, Plant & Equipment $1.860M $1.100M
YoY Change 69.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.860M $1.100M
YoY Change 69.08%
TOTAL ASSETS
Total Short-Term Assets $38.84M $37.56M
Total Long-Term Assets $1.860M $1.100M
Total Assets $40.70M $38.66M
YoY Change 5.27% 32.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.494M $1.300M
YoY Change 14.91% 217.07%
Accrued Expenses $416.9K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.961M $1.320M
YoY Change 48.54% 221.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.961M $1.320M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.961M $1.320M
YoY Change 48.54% -14.29%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $38.74M $37.34M
YoY Change
Total Liabilities & Shareholders Equity $40.70M $38.66M
YoY Change 5.27% 32.44%

Cashflow Statement

Concept 2021 2020
OPERATING ACTIVITIES
Net Income -$31.04M -$18.57M
YoY Change 67.14% 56.44%
Depreciation, Depletion And Amortization $111.5K $0.00
YoY Change
Cash From Operating Activities -$29.56M -$16.62M
YoY Change 77.84% 48.13%
INVESTING ACTIVITIES
Capital Expenditures -$868.5K -$1.100M
YoY Change -21.04%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$868.5K -$1.100M
YoY Change -21.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 28.88M 24.99M
YoY Change 15.59% -13.98%
NET CHANGE
Cash From Operating Activities -29.56M -16.62M
Cash From Investing Activities -868.5K -1.100M
Cash From Financing Activities 28.88M 24.99M
Net Change In Cash -1.541M 7.270M
YoY Change -121.19% -59.23%
FREE CASH FLOW
Cash From Operating Activities -$29.56M -$16.62M
Capital Expenditures -$868.5K -$1.100M
Free Cash Flow -$28.69M -$15.52M
YoY Change 84.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 tffp Research And Development Tax Incentive Receivable
ResearchAndDevelopmentTaxIncentiveReceivable
USD
CY2020Q4 tffp Accrued Compensation Liabilities
AccruedCompensationLiabilities
USD
CY2020 us-gaap Revenues
Revenues
USD
CY2020 us-gaap Other Income
OtherIncome
USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
USD
CY2020 tffp Receivable Due From Collaborations Agreement
ReceivableDueFromCollaborationsAgreement
USD
CY2020 tffp Research And Development Tax Incentive Receivables
ResearchAndDevelopmentTaxIncentiveReceivables
USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
CY2021 tffp Conversion Of Series Preferred Stock Including Accrued Dividends To Common Stock
ConversionOfSeriesPreferredStockIncludingAccruedDividendsToCommonStock
USD
CY2020 tffp Weightedaverage Remaining Contractual Term Granted
WeightedaverageRemainingContractualTermGranted
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
USD
CY2020 tffp Weightedaverage Remaining Contractual Term Cancelled
WeightedaverageRemainingContractualTermCancelled
CY2020 tffp Aggregate Intrinsic Value Cancelled
AggregateIntrinsicValueCancelled
USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
USD
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
USD
CY2021 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
USD
CY2020 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
pure

Files In Submission

Name View Source Status
0001213900-22-014844-index-headers.html Edgar Link pending
0001213900-22-014844-index.html Edgar Link pending
0001213900-22-014844.txt Edgar Link pending
0001213900-22-014844-xbrl.zip Edgar Link pending
f10k2021ex23-1_tffpharma.htm Edgar Link pending
f10k2021ex31-1_tffpharma.htm Edgar Link pending
f10k2021ex31-2_tffpharma.htm Edgar Link pending
f10k2021ex32-1_tffpharma.htm Edgar Link pending
f10k2021_tffpharma.htm Edgar Link pending
f10k2021_tffpharma_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img_001.jpg Edgar Link pending
img_002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tffp-20211231.xsd Edgar Link pending
tffp-20211231_cal.xml Edgar Link unprocessable
tffp-20211231_def.xml Edgar Link unprocessable
tffp-20211231_lab.xml Edgar Link unprocessable
tffp-20211231_pre.xml Edgar Link unprocessable